The South African Substance Abuse Treatment Market is estimated to grow at a strong CAGR of 8.78% during the review period. Common treatment approaches include detoxification, counseling, medication-assisted treatment (MAT), and rehabilitation programs, all tailored to the individual's needs.
The South African substance addiction treatment industry is being driven by rising drug and alcohol consumption, as well as increased treatment program funding. Furthermore, stigma and discrimination in the society, as well as voluntary product recalls by market players, are limiting the growth of South Africa's substance misuse treatment market. However, government support and initiatives, as well as public awareness and education, will create future growth potential for the market.
Market Segmentation
The South African substance abuse treatment market is divided into three segments based on treatment type: alcohol addiction therapy, drug abuse treatment, and tobacco/nicotine addiction treatment.
The market is divided into two segments based on the route of administration: oral and intravenous treatment.
South Africa's substance addiction treatment market is divided into three segments based on end user: hospitals and clinics, private rehabilitation treatment centres, and others.
Major Players
Teva Pharmaceutical Industries Ltd., GSK Plc, Pfizer Inc., Sun Pharmaceutical Industries Ltd, Mallinckrodt PLC, and Adcock Ingram are the leading participants in South Africa's substance addiction treatment industry.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook